Podcast: Pharma insiders clash over COVID IP waiver

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Podcast: Pharma insiders clash over COVID IP waiver

covid-waiver-min.jpeg

Guests from IFPMA, Knowledge Ecology International and Gowling WLG debate the necessity of waiving IP rights to COVID-19 vaccines

Earlier this month, US President Joe Biden shocked the pharmaceutical industry with his declared support for an intellectual property waiver for COVID-19 vaccines.

In this special podcast, reporter Charlotte Kilpatrick moderates a debate between Komal Kalha, lead for IP and trade policy at the International Federation of Pharmaceutical Manufacturers & Associations; James Love, director of Knowledge Ecology International; and Gordon Harris, partner at Gowling WLG.

In this heated debate, guests discuss the flexibilities of the TRIPS Agreement, know-how gaps, and whether the waiver – if implemented – could undermine incentives for future pharmaceutical research.

To listen to the 30-minute debate, click the link below.



 


more from across site and SHARED ros bottom lb

More from across our site

A $110 million US verdict against Apple and an appellate order staying a $39 million trademark infringement finding against Amazon were also among the top talking points
Attorneys are watching how AI affects trademark registrations and whether a SCOTUS ruling from last year will have broader free speech implications
Patent lawyers explain why they will be keeping an eye on the implications of a pharma case and on changes at the USPTO in the second half of 2025
The insensitive reaction to a UK politician crying on TV proves we have a long way to go before we can say we are tackling workplace wellbeing
Adrian Percer says he was impressed by the firm’s work on billion-dollar cases as well as its culture
In our latest interview with women IP leaders, Catherine Bonner at Murgitroyd discusses technology, training, and teaching
Developments included an update in the VAR dispute between Ballinno and UEFA, the latest CMS updates, and a swathe of market moves
The LMG Life Sciences Americas Awards is thrilled to present the 2025 shortlist
A new order has brought the total security awarded to a Canadian tech company to $45 million, the highest-ever by an Indian court in an IP case
Andrew Blattman reflects on how IP practices have changed and shares his hopes for increased AI use and better performance on the stock market
Gift this article